Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, Dr.Ulrike Lorch, Nobuo Ittetsu, and Minoru Takada will be attending BioJapan 2024in Yokohama. As Asia’s premier partnering event for the global biotechnologyindustry, BioJapan offers an unparalleled opportunity to engage with leaders inlife sciences, explore new business opportunities, and discuss the latestinnovations in biotechnology. The event will feature networking sessions,exhibitions, and one-on-one partnering meetings, making it a crucial gatheringfor industry professionals.
Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy
September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.